Polish-American startup Mos Health plans to build an AI-based platform for personalised health protocols and supplements in the US.
Mos Health, a Polish-American startup developing an AI-based health platform for personalised protocols and supplements, has raised $1.1 million in a pre-seed round co-led by SMOK Ventures and Movens Capital, with participation from Tomasz Karwatka, Piotr Karwatka, Anna Lankauf, and others.
Mos Health is a preventive health and lifestyle wellness company focused on making health solutions practical for everyday use. With only 25 per cent of U.S. adults meeting recommended activity levels and many diets failing due to low adherence, the company aims to address an execution gap by combining personalised guidance with tools that support consistent action.
The platform is built around two integrated components. The AI Health Partner app analyses data from sleep, nutrition, lab tests, and wearable devices such as Apple Watch and Oura to generate personalised health protocols. This is complemented by a proprietary line of supplements produced with a U.S.-based manufacturing partner, designed to support implementation of the app’s recommendations.
Patrycja Brzozowska, founder and CEO of Mos Health, said the company was created out of her own challenges with maintaining consistency.
Generic advice is often not enough, so we are building a system that uses personal data and reduces friction in day-to-day execution,
Brzozowska said.
Mos Health is launching in the US with a B2B2C model that enables employers to offer personalised health protocols and supplements as part of their employee benefits.
Commenting on the US launch, Paweł Chrzan, co-founder of Mos Health, said the market enables faster adoption of innovation by companies and users.
The employee benefits model aligns well with our approach, as the workplace is often where sustainable lifestyle changes can be introduced,
Chrzan added.
The company plans to use the funding to develop its MVP, advance its core technology, and begin initial deployments in the US.